Tuesday January 10, 2017
A trial evaluating screening ultrasound after tomosynthesis (3D mammography) is ongoing at the University of Pittsburgh School of Medicine/UPMC. The study is funded by the National Cancer Institute and the Pennsylvania Breast Cancer Coalition and will recruit 6,200 women. Participants will receive screening ultrasound each year for three years as part of the study provided 3D mammography is included as part of their usual breast screening. Results are expected in late 2021.